Scenarios that move GH

Guardant Health, Inc. - Common Stock

Scenarios that move GH: 2 analyses, 1 positive, 1 negative.

1. 2026-10-16 · OPKO Health to sell BioReference assets to Labcorp for $722M — ▼ · impact -17 · confidence medium · horizon quarters
2. 2026-09-14 · AstraZeneca's Etcamah fails late-stage study in first-line breast cancer — ▲ · impact +40 · confidence low · horizon quarters

All scenarios · Run a scenario · Pricing